Basic Information
TearClear is an emerging ophthalmic pharmaceutical company aiming to disrupt the current method of delivering topical drugs to the ocular surface. TearClear's leading candidate product for glaucoma will pave the way for future indications across multiple programs in development. This first-of-its-kind drug platform enables drug delivery by capturing preservatives before they reach the ocular surface, ultimately enhancing patient safety and compliance.